Global Antibody Discovery Market by Nature (Chimeric, Human, Humanized, Murine), by Method (Transgenic Animal, Hybridoma, Single Cell, Phage Display, Yeast Display), by End Users (Pharmaceutical, Biotechnology Companies, Research Laboratories), by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Antibody Discovery Market research report which is segmented by Nature (Chimeric, Human, Humanized, Murine), by Method (Transgenic Animal, Hybridoma, Single Cell, Phage Display, Yeast Display), by End Users (Pharmaceutical, Biotechnology Companies, Research Laboratories), by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies), By Players/Companies Bruker Corporation., Major players analyzed Include Twist Bioscience Corporation, Alcami Corporation Inc., BASF SE., PHARMA’S ALMANAC (That’s Nice LLC)., Eurofins DiscoverX Products LLC., PharmaCircle LLC., Croda International Plc., Cambrex Corporation., BioDuro-Sundia., Frontage Laboratories Inc.”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Antibody Discovery Market Research Report |
| By Nature | Chimeric, Human, Humanized, Murine |
| By Method | Transgenic Animal, Hybridoma, Single Cell, Phage Display, Yeast Display |
| By End Users | Pharmaceutical, Biotechnology Companies, Research Laboratories |
| By Antibody Type | Monoclonal Antibodies, Polyclonal Antibodies |
| By Companies | Bruker Corporation., Major players analyzed Include Twist Bioscience Corporation, Alcami Corporation Inc., BASF SE., PHARMA’S ALMANAC (That’s Nice LLC)., Eurofins DiscoverX Products LLC., PharmaCircle LLC., Croda International Plc., Cambrex Corporation., BioDuro-Sundia., Frontage Laboratories Inc. |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 230 |
| Number of Tables & Figures | 161 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Antibody Discovery Market Report Segments:
The market is segmented by Nature (Chimeric, Human, Humanized, Murine), by Method (Transgenic Animal, Hybridoma, Single Cell, Phage Display, Yeast Display), by End Users (Pharmaceutical, Biotechnology Companies, Research Laboratories), by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies).
Antibody Discovery Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Antibody Discovery Market
Overview of the regional outlook of the Antibody Discovery Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Antibody Discovery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Antibody Discovery Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Chimeric
2. Human
3. Humanized
4. Murine
7. By Method:1. Transgenic Animal
2. Hybridoma
3. Single Cell
4. Phage Display
5. Yeast Display
8. By End Users:1. Pharmaceutical
2. Biotechnology Companies
3. Research Laboratories
9. By Antibody Type:1. Monoclonal Antibodies
2. Polyclonal Antibodies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antibody Discovery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Antibody Discovery Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antibody Discovery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antibody Discovery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antibody Discovery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antibody Discovery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antibody Discovery Market Size & Forecast, 2018-2028
4.5.1 Antibody Discovery Market Size and Y-o-Y Growth
4.5.2 Antibody Discovery Market Absolute $ Opportunity
Chapter 5 Global Antibody Discovery Market Analysis and Forecast by Nature
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Nature
5.1.2 Basis Point Share (BPS) Analysis by Nature
5.1.3 Absolute $ Opportunity Assessment by Nature
5.2 Antibody Discovery Market Size Forecast by Nature
5.2.1 Chimeric
5.2.2 Human
5.2.3 Humanized
5.2.4 Murine
5.3 Market Attractiveness Analysis by Nature
Chapter 6 Global Antibody Discovery Market Analysis and Forecast by Method
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Method
6.1.2 Basis Point Share (BPS) Analysis by Method
6.1.3 Absolute $ Opportunity Assessment by Method
6.2 Antibody Discovery Market Size Forecast by Method
6.2.1 Transgenic Animal
6.2.2 Hybridoma
6.2.3 Single Cell
6.2.4 Phage Display
6.2.5 Yeast Display
6.3 Market Attractiveness Analysis by Method
Chapter 7 Global Antibody Discovery Market Analysis and Forecast by End Users
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by End Users
7.1.2 Basis Point Share (BPS) Analysis by End Users
7.1.3 Absolute $ Opportunity Assessment by End Users
7.2 Antibody Discovery Market Size Forecast by End Users
7.2.1 Pharmaceutical
7.2.2 Biotechnology Companies
7.2.3 Research Laboratories
7.3 Market Attractiveness Analysis by End Users
Chapter 8 Global Antibody Discovery Market Analysis and Forecast by Antibody Type
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Antibody Type
8.1.2 Basis Point Share (BPS) Analysis by Antibody Type
8.1.3 Absolute $ Opportunity Assessment by Antibody Type
8.2 Antibody Discovery Market Size Forecast by Antibody Type
8.2.1 Monoclonal Antibodies
8.2.2 Polyclonal Antibodies
8.3 Market Attractiveness Analysis by Antibody Type
Chapter 9 Global Antibody Discovery Market Analysis and Forecast by Region
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Region
9.1.2 Basis Point Share (BPS) Analysis by Region
9.1.3 Absolute $ Opportunity Assessment by Region
9.2 Antibody Discovery Market Size Forecast by Region
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa (MEA)
9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
10.1 Introduction
10.2 Current & Future Impact Analysis
10.3 Economic Impact Analysis
10.4 Government Policies
10.5 Investment Scenario
Chapter 11 North America Antibody Discovery Analysis and Forecast
11.1 Introduction
11.2 North America Antibody Discovery Market Size Forecast by Country
11.2.1 U.S.
11.2.2 Canada
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 North America Antibody Discovery Market Size Forecast by Nature
11.6.1 Chimeric
11.6.2 Human
11.6.3 Humanized
11.6.4 Murine
11.7 Basis Point Share (BPS) Analysis by Nature
11.8 Absolute $ Opportunity Assessment by Nature
11.9 Market Attractiveness Analysis by Nature
11.10 North America Antibody Discovery Market Size Forecast by Method
11.10.1 Transgenic Animal
11.10.2 Hybridoma
11.10.3 Single Cell
11.10.4 Phage Display
11.10.5 Yeast Display
11.11 Basis Point Share (BPS) Analysis by Method
11.12 Absolute $ Opportunity Assessment by Method
11.13 Market Attractiveness Analysis by Method
11.14 North America Antibody Discovery Market Size Forecast by End Users
11.14.1 Pharmaceutical
11.14.2 Biotechnology Companies
11.14.3 Research Laboratories
11.15 Basis Point Share (BPS) Analysis by End Users
11.16 Absolute $ Opportunity Assessment by End Users
11.17 Market Attractiveness Analysis by End Users
11.18 North America Antibody Discovery Market Size Forecast by Antibody Type
11.18.1 Monoclonal Antibodies
11.18.2 Polyclonal Antibodies
11.19 Basis Point Share (BPS) Analysis by Antibody Type
11.20 Absolute $ Opportunity Assessment by Antibody Type
11.21 Market Attractiveness Analysis by Antibody Type
Chapter 12 Europe Antibody Discovery Analysis and Forecast
12.1 Introduction
12.2 Europe Antibody Discovery Market Size Forecast by Country
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 U.K.
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Europe Antibody Discovery Market Size Forecast by Nature
12.6.1 Chimeric
12.6.2 Human
12.6.3 Humanized
12.6.4 Murine
12.7 Basis Point Share (BPS) Analysis by Nature
12.8 Absolute $ Opportunity Assessment by Nature
12.9 Market Attractiveness Analysis by Nature
12.10 Europe Antibody Discovery Market Size Forecast by Method
12.10.1 Transgenic Animal
12.10.2 Hybridoma
12.10.3 Single Cell
12.10.4 Phage Display
12.10.5 Yeast Display
12.11 Basis Point Share (BPS) Analysis by Method
12.12 Absolute $ Opportunity Assessment by Method
12.13 Market Attractiveness Analysis by Method
12.14 Europe Antibody Discovery Market Size Forecast by End Users
12.14.1 Pharmaceutical
12.14.2 Biotechnology Companies
12.14.3 Research Laboratories
12.15 Basis Point Share (BPS) Analysis by End Users
12.16 Absolute $ Opportunity Assessment by End Users
12.17 Market Attractiveness Analysis by End Users
12.18 Europe Antibody Discovery Market Size Forecast by Antibody Type
12.18.1 Monoclonal Antibodies
12.18.2 Polyclonal Antibodies
12.19 Basis Point Share (BPS) Analysis by Antibody Type
12.20 Absolute $ Opportunity Assessment by Antibody Type
12.21 Market Attractiveness Analysis by Antibody Type
Chapter 13 Asia Pacific Antibody Discovery Analysis and Forecast
13.1 Introduction
13.2 Asia Pacific Antibody Discovery Market Size Forecast by Country
13.2.1 China
13.2.2 Japan
13.2.3 South Korea
13.2.4 India
13.2.5 Australia
13.2.6 South East Asia (SEA)
13.2.7 Rest of Asia Pacific (APAC)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Asia Pacific Antibody Discovery Market Size Forecast by Nature
13.6.1 Chimeric
13.6.2 Human
13.6.3 Humanized
13.6.4 Murine
13.7 Basis Point Share (BPS) Analysis by Nature
13.8 Absolute $ Opportunity Assessment by Nature
13.9 Market Attractiveness Analysis by Nature
13.10 Asia Pacific Antibody Discovery Market Size Forecast by Method
13.10.1 Transgenic Animal
13.10.2 Hybridoma
13.10.3 Single Cell
13.10.4 Phage Display
13.10.5 Yeast Display
13.11 Basis Point Share (BPS) Analysis by Method
13.12 Absolute $ Opportunity Assessment by Method
13.13 Market Attractiveness Analysis by Method
13.14 Asia Pacific Antibody Discovery Market Size Forecast by End Users
13.14.1 Pharmaceutical
13.14.2 Biotechnology Companies
13.14.3 Research Laboratories
13.15 Basis Point Share (BPS) Analysis by End Users
13.16 Absolute $ Opportunity Assessment by End Users
13.17 Market Attractiveness Analysis by End Users
13.18 Asia Pacific Antibody Discovery Market Size Forecast by Antibody Type
13.18.1 Monoclonal Antibodies
13.18.2 Polyclonal Antibodies
13.19 Basis Point Share (BPS) Analysis by Antibody Type
13.20 Absolute $ Opportunity Assessment by Antibody Type
13.21 Market Attractiveness Analysis by Antibody Type
Chapter 14 Latin America Antibody Discovery Analysis and Forecast
14.1 Introduction
14.2 Latin America Antibody Discovery Market Size Forecast by Country
14.2.1 Brazil
14.2.2 Mexico
14.2.3 Rest of Latin America (LATAM)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Latin America Antibody Discovery Market Size Forecast by Nature
14.6.1 Chimeric
14.6.2 Human
14.6.3 Humanized
14.6.4 Murine
14.7 Basis Point Share (BPS) Analysis by Nature
14.8 Absolute $ Opportunity Assessment by Nature
14.9 Market Attractiveness Analysis by Nature
14.10 Latin America Antibody Discovery Market Size Forecast by Method
14.10.1 Transgenic Animal
14.10.2 Hybridoma
14.10.3 Single Cell
14.10.4 Phage Display
14.10.5 Yeast Display
14.11 Basis Point Share (BPS) Analysis by Method
14.12 Absolute $ Opportunity Assessment by Method
14.13 Market Attractiveness Analysis by Method
14.14 Latin America Antibody Discovery Market Size Forecast by End Users
14.14.1 Pharmaceutical
14.14.2 Biotechnology Companies
14.14.3 Research Laboratories
14.15 Basis Point Share (BPS) Analysis by End Users
14.16 Absolute $ Opportunity Assessment by End Users
14.17 Market Attractiveness Analysis by End Users
14.18 Latin America Antibody Discovery Market Size Forecast by Antibody Type
14.18.1 Monoclonal Antibodies
14.18.2 Polyclonal Antibodies
14.19 Basis Point Share (BPS) Analysis by Antibody Type
14.20 Absolute $ Opportunity Assessment by Antibody Type
14.21 Market Attractiveness Analysis by Antibody Type
Chapter 15 Middle East & Africa (MEA) Antibody Discovery Analysis and Forecast
15.1 Introduction
15.2 Middle East & Africa (MEA) Antibody Discovery Market Size Forecast by Country
15.2.1 Saudi Arabia
15.2.2 South Africa
15.2.3 UAE
15.2.4 Rest of Middle East & Africa (MEA)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Middle East & Africa (MEA) Antibody Discovery Market Size Forecast by Nature
15.6.1 Chimeric
15.6.2 Human
15.6.3 Humanized
15.6.4 Murine
15.7 Basis Point Share (BPS) Analysis by Nature
15.8 Absolute $ Opportunity Assessment by Nature
15.9 Market Attractiveness Analysis by Nature
15.10 Middle East & Africa (MEA) Antibody Discovery Market Size Forecast by Method
15.10.1 Transgenic Animal
15.10.2 Hybridoma
15.10.3 Single Cell
15.10.4 Phage Display
15.10.5 Yeast Display
15.11 Basis Point Share (BPS) Analysis by Method
15.12 Absolute $ Opportunity Assessment by Method
15.13 Market Attractiveness Analysis by Method
15.14 Middle East & Africa (MEA) Antibody Discovery Market Size Forecast by End Users
15.14.1 Pharmaceutical
15.14.2 Biotechnology Companies
15.14.3 Research Laboratories
15.15 Basis Point Share (BPS) Analysis by End Users
15.16 Absolute $ Opportunity Assessment by End Users
15.17 Market Attractiveness Analysis by End Users
15.18 Middle East & Africa (MEA) Antibody Discovery Market Size Forecast by Antibody Type
15.18.1 Monoclonal Antibodies
15.18.2 Polyclonal Antibodies
15.19 Basis Point Share (BPS) Analysis by Antibody Type
15.20 Absolute $ Opportunity Assessment by Antibody Type
15.21 Market Attractiveness Analysis by Antibody Type
Chapter 16 Competition Landscape
16.1 Antibody Discovery Market: Competitive Dashboard
16.2 Global Antibody Discovery Market: Market Share Analysis, 2019
16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
16.3.1 Bruker Corporation.
16.3.2 Major players analyzed Include Twist Bioscience Corporation
16.3.3 Alcami Corporation Inc.
16.3.4 BASF SE.
16.3.5 PHARMA’S ALMANAC (That’s Nice LLC).
16.3.6 Eurofins DiscoverX Products LLC.
16.3.7 PharmaCircle LLC.
16.3.8 Croda International Plc.
16.3.9 Cambrex Corporation.
16.3.10 BioDuro-Sundia.
16.3.11 Frontage Laboratories Inc.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antibody Discovery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antibody Discovery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antibody Discovery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antibody Discovery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antibody Discovery Market Size & Forecast, 2018-2028
4.5.1 Antibody Discovery Market Size and Y-o-Y Growth
4.5.2 Antibody Discovery Market Absolute $ Opportunity
Chapter 5 Global Antibody Discovery Market Analysis and Forecast by Nature
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Nature
5.1.2 Basis Point Share (BPS) Analysis by Nature
5.1.3 Absolute $ Opportunity Assessment by Nature
5.2 Antibody Discovery Market Size Forecast by Nature
5.2.1 Chimeric
5.2.2 Human
5.2.3 Humanized
5.2.4 Murine
5.3 Market Attractiveness Analysis by Nature
Chapter 6 Global Antibody Discovery Market Analysis and Forecast by Method
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Method
6.1.2 Basis Point Share (BPS) Analysis by Method
6.1.3 Absolute $ Opportunity Assessment by Method
6.2 Antibody Discovery Market Size Forecast by Method
6.2.1 Transgenic Animal
6.2.2 Hybridoma
6.2.3 Single Cell
6.2.4 Phage Display
6.2.5 Yeast Display
6.3 Market Attractiveness Analysis by Method
Chapter 7 Global Antibody Discovery Market Analysis and Forecast by End Users
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by End Users
7.1.2 Basis Point Share (BPS) Analysis by End Users
7.1.3 Absolute $ Opportunity Assessment by End Users
7.2 Antibody Discovery Market Size Forecast by End Users
7.2.1 Pharmaceutical
7.2.2 Biotechnology Companies
7.2.3 Research Laboratories
7.3 Market Attractiveness Analysis by End Users
Chapter 8 Global Antibody Discovery Market Analysis and Forecast by Antibody Type
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Antibody Type
8.1.2 Basis Point Share (BPS) Analysis by Antibody Type
8.1.3 Absolute $ Opportunity Assessment by Antibody Type
8.2 Antibody Discovery Market Size Forecast by Antibody Type
8.2.1 Monoclonal Antibodies
8.2.2 Polyclonal Antibodies
8.3 Market Attractiveness Analysis by Antibody Type
Chapter 9 Global Antibody Discovery Market Analysis and Forecast by Region
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Region
9.1.2 Basis Point Share (BPS) Analysis by Region
9.1.3 Absolute $ Opportunity Assessment by Region
9.2 Antibody Discovery Market Size Forecast by Region
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa (MEA)
9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
10.1 Introduction
10.2 Current & Future Impact Analysis
10.3 Economic Impact Analysis
10.4 Government Policies
10.5 Investment Scenario
Chapter 11 North America Antibody Discovery Analysis and Forecast
11.1 Introduction
11.2 North America Antibody Discovery Market Size Forecast by Country
11.2.1 U.S.
11.2.2 Canada
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 North America Antibody Discovery Market Size Forecast by Nature
11.6.1 Chimeric
11.6.2 Human
11.6.3 Humanized
11.6.4 Murine
11.7 Basis Point Share (BPS) Analysis by Nature
11.8 Absolute $ Opportunity Assessment by Nature
11.9 Market Attractiveness Analysis by Nature
11.10 North America Antibody Discovery Market Size Forecast by Method
11.10.1 Transgenic Animal
11.10.2 Hybridoma
11.10.3 Single Cell
11.10.4 Phage Display
11.10.5 Yeast Display
11.11 Basis Point Share (BPS) Analysis by Method
11.12 Absolute $ Opportunity Assessment by Method
11.13 Market Attractiveness Analysis by Method
11.14 North America Antibody Discovery Market Size Forecast by End Users
11.14.1 Pharmaceutical
11.14.2 Biotechnology Companies
11.14.3 Research Laboratories
11.15 Basis Point Share (BPS) Analysis by End Users
11.16 Absolute $ Opportunity Assessment by End Users
11.17 Market Attractiveness Analysis by End Users
11.18 North America Antibody Discovery Market Size Forecast by Antibody Type
11.18.1 Monoclonal Antibodies
11.18.2 Polyclonal Antibodies
11.19 Basis Point Share (BPS) Analysis by Antibody Type
11.20 Absolute $ Opportunity Assessment by Antibody Type
11.21 Market Attractiveness Analysis by Antibody Type
Chapter 12 Europe Antibody Discovery Analysis and Forecast
12.1 Introduction
12.2 Europe Antibody Discovery Market Size Forecast by Country
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 U.K.
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Europe Antibody Discovery Market Size Forecast by Nature
12.6.1 Chimeric
12.6.2 Human
12.6.3 Humanized
12.6.4 Murine
12.7 Basis Point Share (BPS) Analysis by Nature
12.8 Absolute $ Opportunity Assessment by Nature
12.9 Market Attractiveness Analysis by Nature
12.10 Europe Antibody Discovery Market Size Forecast by Method
12.10.1 Transgenic Animal
12.10.2 Hybridoma
12.10.3 Single Cell
12.10.4 Phage Display
12.10.5 Yeast Display
12.11 Basis Point Share (BPS) Analysis by Method
12.12 Absolute $ Opportunity Assessment by Method
12.13 Market Attractiveness Analysis by Method
12.14 Europe Antibody Discovery Market Size Forecast by End Users
12.14.1 Pharmaceutical
12.14.2 Biotechnology Companies
12.14.3 Research Laboratories
12.15 Basis Point Share (BPS) Analysis by End Users
12.16 Absolute $ Opportunity Assessment by End Users
12.17 Market Attractiveness Analysis by End Users
12.18 Europe Antibody Discovery Market Size Forecast by Antibody Type
12.18.1 Monoclonal Antibodies
12.18.2 Polyclonal Antibodies
12.19 Basis Point Share (BPS) Analysis by Antibody Type
12.20 Absolute $ Opportunity Assessment by Antibody Type
12.21 Market Attractiveness Analysis by Antibody Type
Chapter 13 Asia Pacific Antibody Discovery Analysis and Forecast
13.1 Introduction
13.2 Asia Pacific Antibody Discovery Market Size Forecast by Country
13.2.1 China
13.2.2 Japan
13.2.3 South Korea
13.2.4 India
13.2.5 Australia
13.2.6 South East Asia (SEA)
13.2.7 Rest of Asia Pacific (APAC)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Asia Pacific Antibody Discovery Market Size Forecast by Nature
13.6.1 Chimeric
13.6.2 Human
13.6.3 Humanized
13.6.4 Murine
13.7 Basis Point Share (BPS) Analysis by Nature
13.8 Absolute $ Opportunity Assessment by Nature
13.9 Market Attractiveness Analysis by Nature
13.10 Asia Pacific Antibody Discovery Market Size Forecast by Method
13.10.1 Transgenic Animal
13.10.2 Hybridoma
13.10.3 Single Cell
13.10.4 Phage Display
13.10.5 Yeast Display
13.11 Basis Point Share (BPS) Analysis by Method
13.12 Absolute $ Opportunity Assessment by Method
13.13 Market Attractiveness Analysis by Method
13.14 Asia Pacific Antibody Discovery Market Size Forecast by End Users
13.14.1 Pharmaceutical
13.14.2 Biotechnology Companies
13.14.3 Research Laboratories
13.15 Basis Point Share (BPS) Analysis by End Users
13.16 Absolute $ Opportunity Assessment by End Users
13.17 Market Attractiveness Analysis by End Users
13.18 Asia Pacific Antibody Discovery Market Size Forecast by Antibody Type
13.18.1 Monoclonal Antibodies
13.18.2 Polyclonal Antibodies
13.19 Basis Point Share (BPS) Analysis by Antibody Type
13.20 Absolute $ Opportunity Assessment by Antibody Type
13.21 Market Attractiveness Analysis by Antibody Type
Chapter 14 Latin America Antibody Discovery Analysis and Forecast
14.1 Introduction
14.2 Latin America Antibody Discovery Market Size Forecast by Country
14.2.1 Brazil
14.2.2 Mexico
14.2.3 Rest of Latin America (LATAM)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Latin America Antibody Discovery Market Size Forecast by Nature
14.6.1 Chimeric
14.6.2 Human
14.6.3 Humanized
14.6.4 Murine
14.7 Basis Point Share (BPS) Analysis by Nature
14.8 Absolute $ Opportunity Assessment by Nature
14.9 Market Attractiveness Analysis by Nature
14.10 Latin America Antibody Discovery Market Size Forecast by Method
14.10.1 Transgenic Animal
14.10.2 Hybridoma
14.10.3 Single Cell
14.10.4 Phage Display
14.10.5 Yeast Display
14.11 Basis Point Share (BPS) Analysis by Method
14.12 Absolute $ Opportunity Assessment by Method
14.13 Market Attractiveness Analysis by Method
14.14 Latin America Antibody Discovery Market Size Forecast by End Users
14.14.1 Pharmaceutical
14.14.2 Biotechnology Companies
14.14.3 Research Laboratories
14.15 Basis Point Share (BPS) Analysis by End Users
14.16 Absolute $ Opportunity Assessment by End Users
14.17 Market Attractiveness Analysis by End Users
14.18 Latin America Antibody Discovery Market Size Forecast by Antibody Type
14.18.1 Monoclonal Antibodies
14.18.2 Polyclonal Antibodies
14.19 Basis Point Share (BPS) Analysis by Antibody Type
14.20 Absolute $ Opportunity Assessment by Antibody Type
14.21 Market Attractiveness Analysis by Antibody Type
Chapter 15 Middle East & Africa (MEA) Antibody Discovery Analysis and Forecast
15.1 Introduction
15.2 Middle East & Africa (MEA) Antibody Discovery Market Size Forecast by Country
15.2.1 Saudi Arabia
15.2.2 South Africa
15.2.3 UAE
15.2.4 Rest of Middle East & Africa (MEA)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Middle East & Africa (MEA) Antibody Discovery Market Size Forecast by Nature
15.6.1 Chimeric
15.6.2 Human
15.6.3 Humanized
15.6.4 Murine
15.7 Basis Point Share (BPS) Analysis by Nature
15.8 Absolute $ Opportunity Assessment by Nature
15.9 Market Attractiveness Analysis by Nature
15.10 Middle East & Africa (MEA) Antibody Discovery Market Size Forecast by Method
15.10.1 Transgenic Animal
15.10.2 Hybridoma
15.10.3 Single Cell
15.10.4 Phage Display
15.10.5 Yeast Display
15.11 Basis Point Share (BPS) Analysis by Method
15.12 Absolute $ Opportunity Assessment by Method
15.13 Market Attractiveness Analysis by Method
15.14 Middle East & Africa (MEA) Antibody Discovery Market Size Forecast by End Users
15.14.1 Pharmaceutical
15.14.2 Biotechnology Companies
15.14.3 Research Laboratories
15.15 Basis Point Share (BPS) Analysis by End Users
15.16 Absolute $ Opportunity Assessment by End Users
15.17 Market Attractiveness Analysis by End Users
15.18 Middle East & Africa (MEA) Antibody Discovery Market Size Forecast by Antibody Type
15.18.1 Monoclonal Antibodies
15.18.2 Polyclonal Antibodies
15.19 Basis Point Share (BPS) Analysis by Antibody Type
15.20 Absolute $ Opportunity Assessment by Antibody Type
15.21 Market Attractiveness Analysis by Antibody Type
Chapter 16 Competition Landscape
16.1 Antibody Discovery Market: Competitive Dashboard
16.2 Global Antibody Discovery Market: Market Share Analysis, 2019
16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
16.3.1 Bruker Corporation.
16.3.2 Major players analyzed Include Twist Bioscience Corporation
16.3.3 Alcami Corporation Inc.
16.3.4 BASF SE.
16.3.5 PHARMA’S ALMANAC (That’s Nice LLC).
16.3.6 Eurofins DiscoverX Products LLC.
16.3.7 PharmaCircle LLC.
16.3.8 Croda International Plc.
16.3.9 Cambrex Corporation.
16.3.10 BioDuro-Sundia.
16.3.11 Frontage Laboratories Inc.
Segments Covered in the Report
The global Antibody Discovery market has been segmented based on
By Nature
The global Antibody Discovery market has been segmented based on
By Nature
- Chimeric
- Human
- Humanized
- Murine
- Transgenic Animal
- Hybridoma
- Single Cell
- Phage Display
- Yeast Display
- Pharmaceutical
- Biotechnology Companies
- Research Laboratories
- Monoclonal Antibodies
- Polyclonal Antibodies
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Bruker Corporation.
- Major players analyzed Include Twist Bioscience Corporation
- Alcami Corporation Inc.
- BASF SE.
- PHARMA’S ALMANAC (That’s Nice LLC).
- Eurofins DiscoverX Products LLC.
- PharmaCircle LLC.
- Croda International Plc.
- Cambrex Corporation.
- BioDuro-Sundia.
- Frontage Laboratories Inc.
Our Clients
Related Reports
Some other reports from this category!
